Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yi-Nan Liu

Showing results (61-70 of 100) with videos related to

Pageof 10
Sort By:
CNS Neuroscience & Therapeutics|February 6, 2019
Modeling vanishing white matter disease with patient-derived induced pluripotent stem cells reveals astrocytic dysfunctionLing Zhou, Peng Li, Na Chen, et al.
Phytochemistry|April 22, 2021
Acylphloroglucinol derivatives with ATP citrate lyase inhibitory activities from Syzygium oblatum WallJin-Chang Huang, Yi-Nan Liu, Yun-Hua Tao, et al.
Cancer Biomarkers : Section a of Disease Markers|May 18, 2020
MiR-200c-3p suppression is associated with development of acquired resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR mutant non-small cell lung cancer via a mediating epithelial-to-mesenchymal transition (EMT) processHsin-Yi Wang, Yi-Nan Liu, Shang-Gin Wu, et al.
Molecular Therapy. Nucleic Acids|December 22, 2023
miR-204 suppresses cancer stemness and enhances osimertinib sensitivity in non-small cell lung cancer by targeting CD44Shang-Gin Wu, Tzu-Hua Chang, Meng-Feng Tsai, et al.
Frontiers in Oncology|March 25, 2021
A Substage Increase in The AJCC Classification System Improves Prognostic Prediction in Stage III Gastric Cancer With Insufficient Lymph Nodes RemovedRi-Sheng Zhao, Yi-Nan Liu, Wei-Gang Dai, et al.
Journal of Medicinal Chemistry|August 4, 2009
Antitumor agents 268. Design, synthesis, and mechanistic studies of new 9-substituted phenanthrene-based tylophorine analogues as potent cytotoxic agentsXiaoming Yang, Qian Shi, Yi-Nan Liu, et al.
Shock (Augusta, Ga.)|December 25, 2008
Evodiamine represses hypoxia-induced inflammatory proteins expression and hypoxia-inducible factor 1alpha accumulation in RAW264.7Yi-Nan Liu, Shiow-Lin Pan, Cho-Hwa Liao, et al.
Thrombosis and Haemostasis|December 8, 2004
The indazole derivative YD-3 inhibits thrombin-induced vascular smooth muscle cell proliferation and attenuates intimal thickening after balloon injuryChieh-Yu Peng, Shiow-Lin Pan, Jih-Hwa Guh, et al.
Molecular Therapy. Nucleic Acids|November 24, 2020
miR-146b-5p Enhances the Sensitivity of NSCLC to EGFR Tyrosine Kinase Inhibitors by Regulating the IRAK1/NF-κB PathwayYi-Nan Liu, Meng-Feng Tsai, Shang-Gin Wu, et al.
Shock (Augusta, Ga.)|January 17, 2008
YC-1 induces heat shock protein 70 expression and prevents oxidized LDL-mediated apoptosis in vascular smooth muscle cellsYi-Nan Liu, Shiow-Lin Pan, Chieh-Yu Peng, et al.
Pageof 10

Showing results (61-70 of 100) with videos related to

Sort By:
Pageof 10
CNS Neuroscience & Therapeutics|February 6, 2019
Modeling vanishing white matter disease with patient-derived induced pluripotent stem cells reveals astrocytic dysfunctionLing Zhou, Peng Li, Na Chen, et al.
Phytochemistry|April 22, 2021
Acylphloroglucinol derivatives with ATP citrate lyase inhibitory activities from Syzygium oblatum WallJin-Chang Huang, Yi-Nan Liu, Yun-Hua Tao, et al.
Cancer Biomarkers : Section a of Disease Markers|May 18, 2020
MiR-200c-3p suppression is associated with development of acquired resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR mutant non-small cell lung cancer via a mediating epithelial-to-mesenchymal transition (EMT) processHsin-Yi Wang, Yi-Nan Liu, Shang-Gin Wu, et al.
Molecular Therapy. Nucleic Acids|December 22, 2023
miR-204 suppresses cancer stemness and enhances osimertinib sensitivity in non-small cell lung cancer by targeting CD44Shang-Gin Wu, Tzu-Hua Chang, Meng-Feng Tsai, et al.
Frontiers in Oncology|March 25, 2021
A Substage Increase in The AJCC Classification System Improves Prognostic Prediction in Stage III Gastric Cancer With Insufficient Lymph Nodes RemovedRi-Sheng Zhao, Yi-Nan Liu, Wei-Gang Dai, et al.
Journal of Medicinal Chemistry|August 4, 2009
Antitumor agents 268. Design, synthesis, and mechanistic studies of new 9-substituted phenanthrene-based tylophorine analogues as potent cytotoxic agentsXiaoming Yang, Qian Shi, Yi-Nan Liu, et al.
Shock (Augusta, Ga.)|December 25, 2008
Evodiamine represses hypoxia-induced inflammatory proteins expression and hypoxia-inducible factor 1alpha accumulation in RAW264.7Yi-Nan Liu, Shiow-Lin Pan, Cho-Hwa Liao, et al.
Thrombosis and Haemostasis|December 8, 2004
The indazole derivative YD-3 inhibits thrombin-induced vascular smooth muscle cell proliferation and attenuates intimal thickening after balloon injuryChieh-Yu Peng, Shiow-Lin Pan, Jih-Hwa Guh, et al.
Molecular Therapy. Nucleic Acids|November 24, 2020
miR-146b-5p Enhances the Sensitivity of NSCLC to EGFR Tyrosine Kinase Inhibitors by Regulating the IRAK1/NF-κB PathwayYi-Nan Liu, Meng-Feng Tsai, Shang-Gin Wu, et al.
Shock (Augusta, Ga.)|January 17, 2008
YC-1 induces heat shock protein 70 expression and prevents oxidized LDL-mediated apoptosis in vascular smooth muscle cellsYi-Nan Liu, Shiow-Lin Pan, Chieh-Yu Peng, et al.
Pageof 10